Friday, February 27, 2015

Mirati begins dosage in MGCD265 Phase 1b clinical trial for NSCLC

›
Mirati Therapeutics, Inc. (NASDAQ: MRTX) today announced that the first patient with Non-Small Cell Lung Cancer (NSCLC) has been dosed in ...
1 comment:
Thursday, February 26, 2015

FDA approves Namzaric drug for treatment of moderate to severe Alzheimer's disease

›
FDA approves Namzaric drug for treatment of moderate to severe Alzheimer's disease
Wednesday, February 25, 2015

Pre-clinical studies confirm TRXE-009 as new potential treatment for melanoma

›
Novogen Limited (ASX:NRT; NASDAQ: NVGN), Australian/US biotechnology company, announces that it has confirmed that its lead candidate prod...
Monday, February 23, 2015

Isis Pharmaceuticals begins ISIS-DMPK Rx clinical study in DM1 patients

›
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced  that it has initiated a study for ISIS-DMPK Rx  in patients with Myotonic Dystrophy T...
Friday, February 20, 2015

Researchers identify 53 existing drugs that may block Ebola virus from entering human cells

›
Researchers found 53 existing drugs that may keep the Ebola virus from entering human cells, a key step in the process of infection, ac...
Thursday, February 19, 2015

Study shows how cannabidiol works within cells

›
A team of Stony Brook University researchers have identified fatty acid binding proteins (FABPs) as intracellular transporters for...
Tuesday, February 17, 2015

Jazz Pharmaceuticals to present defibrotide results for hepatic VOD at BMT Tandem meetings

›
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that researchers will present data on the use of defibrotide, an investigational m...
Monday, February 16, 2015

'Mad Cow' discovery points to possible neuron killing mechanism behind alzheimer’s and parkinson’s diseases

›
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have for the first time discovered a killing mechanism that co...
Wednesday, February 11, 2015

Diabetes drug can boost efficacy of TB medication without causing drug resistance

›
In continuation of my update on  Metformin A more effective treatment for tuberculosis (TB) could soon be available as scientists have...
Tuesday, February 10, 2015

Study: Low glycemic diet does not improve insulin sensitivity or cardiovascular risk factors

›
Study: Low glycemic diet does not improve insulin sensitivity or cardiovascular risk factors
Monday, February 9, 2015

FL118 agent shows efficacy as personalized, targeted therapy for certain cancer tumors

›
A team led by Fengzhi Li, PhD, and Xinjiang Wang, PhD, of Roswell Park Cancer Institute (RPCI) has reported new findings regard...
Friday, February 6, 2015

Addition of S-1 to cisplatin plus radiotherapy ‘favourable’ in NSCLC

›
In continuation of my update on  cisplatin  and  5-fluorouracil derivative S-1v Research suggests that treatment with cisplatin...
Thursday, February 5, 2015

First-line dacomitinib may improve advanced NSCLC survival

›
  Preliminary research suggests that the second-generation tyrosine kinase inhibitor (TKI) dacomitinib  (see right structure)may i...
Wednesday, February 4, 2015

Isis announces top-line results from ISIS-PTP1B Rx Phase 2 study in type 2 diabetes patients

›
Isis announces top-line results from ISIS-PTP1B Rx Phase 2 study in type 2 diabetes patients

Added benefit of daclatasvir drug not proven for chronic hepatitis C infection

›
In continuation of my update on  daclatasvir   The drug daclatasvir (trade name Daklinza) has been available since August 2014 for t...